BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 2408534)

  • 1. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
    Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
    Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma.
    Reiser M; Bruns C; Hartmann P; Salzberger B; Diehl V; Fätkenheuer G
    Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):58-60. PubMed ID: 9512187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
    Dunlop PR; Hendy-Ibbs PM
    Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
    [No Abstract]   [Full Text] [Related]  

  • 4. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma.
    Hladunewich M; Sawka C; Fam A; Franssen E
    J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon following cytotoxic chemotherapy successfully managed by dorsal sympathectomy.
    MacLeod PM; Tyrrell CJ; Bliss B
    Eur J Surg Oncol; 1989 Feb; 15(1):79-81. PubMed ID: 2465189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine and 5-fluorouracil].
    Werquin S; Kacet S; Caron J; Lacroix D; Libersa C; Coget JM; Lekieffre J
    Ann Cardiol Angeiol (Paris); 1987 Oct; 36(8):409-12. PubMed ID: 2445238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raynaud's phenomenon following combined cytostatic treatment of malignant testicular tumours].
    Scheulen ME; Schmidt CG
    Dtsch Med Wochenschr; 1982 Oct; 107(43):1640-4. PubMed ID: 6183087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
    Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
    Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon.
    Lally EV
    Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud's disease after treatment with bleomycin and vinblastine].
    Dzieza-Lalowicz I; Mykała-Cieśla J
    Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
    [No Abstract]   [Full Text] [Related]  

  • 17. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.
    van der Maulen J; Wouda AA; Mandema E; The TH
    Clin Exp Immunol; 1979 Jan; 35(1):62-6. PubMed ID: 428147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.